DAVITA HEALTHCARE PARTNERS INC. 4

4 · DAVITA HEALTHCARE PARTNERS INC. · Filed Dec 21, 2015

Form 4

Period: 2015-12-17

SVP & Chief People Officer

Transactions

Exercise/Conversion
Stock Appreciation Rights
2015-12-17−7,300→ 0 total
Exercise: $43.35From: 2014-04-13Exp: 2016-04-13→ Common Stock (7,300 underlying)
Exercise/Conversion
Common Stock
2015-12-17$43.35/sh+7,300$316,455→ 14,110 total
Sale
Common Stock
2015-12-17$68.13/sh−1,242$84,622→ 8,223 total
Exercise/Conversion
Common Stock
2015-12-17$55.34/sh+2,250$124,515→ 10,473 total
Tax Payment
Common Stock
2015-12-17$68.13/sh−1,828$124,542→ 8,645 total
Tax Payment
Common Stock
2015-12-17$68.13/sh−4,645$316,464→ 9,465 total
Sale
Common Stock
2015-12-17$68.15/sh−198$13,494→ 8,447 total
Exercise/Conversion
Stock Appreciation Rights
2015-12-17−2,250→ 2,250 total
Exercise: $55.34From: 2015-04-01Exp: 2017-12-18→ Common Stock (2,250 underlying)

Footnotes (3)

[F1]Represents the weighted average sale price of $68.1333. The range of prices for the sale of these shares was $68.13 - $68.15, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
[F2]The Stock Appreciation Rights were granted on 4/13/2011 and 50% vested each on 4/13/2014 and 4/13/2015.
[F3]The Stock Appreciation Rights were granted on 12/18/2012 and 50% vested on 4/1/2015.

Documents

1 file